Clinical trial
Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer
NCT00414271 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00414271 |
|---|---|
| Title | Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer |
| Official title | A Phase II Study of Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage T3-4NxM0 Gastric Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel, Capecitabine |
| Enrollment | 18 |
| Start date | Jan 1, 2006 |
| Primary completion | Oct 1, 2015 |
| Completion | Oct 1, 2015 |
| First posted | Dec 21, 2006 |
| Last update posted | Jul 25, 2019 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: